ARALAST Fraction IV-1

alpha 1-antitrypsin · Baxter/Baxalta (now part of Shire)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARALAST Fraction IV-1, covering 2011-01-04 to 2011-01-04. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor) [Phase 4]

See pricing